Sandra Levy
ARTICLES BY THIS AUTHOR
- 10/28/2024
Alvotech, Teva obtain FDA nod for new Selarsdi indication
The FDA approval of Selarsdi 130 mg/26 ml in a single-dose vial for intravenous infusion expands the label to include treatment of adults with Crohn’s disease and ulcerative colitis. - 10/28/2024
Albertsons makes changes to board of directors
Jim Donald was elected as independent chair of the board. - 10/27/2024
Watch DSN: CVS spotlights its vaccination business
Tim Ducharme, vice president of Immunization Growth and Strategy at CVS Health, discusses the company’s vaccination business and its offerings for the respiratory virus season. - 10/27/2024
Natco Pharma’s partner Mylan settles Ozempic patent dispute
The terms of the agreement remain confidential. - 10/27/2024
Kroger extends exchange offers, consent solicitations for Albertsons notes
Kroger also extended the expiration date for the related solicitations of consents to adopt certain proposed amendments to the indentures governing the ACI Notes. - 10/27/2024
Grocery Media Networks represent an $8.5B opportunity to drive growth, study finds
A Grocery Doppio study finds that 68% of grocers say investment in a media network is a high priority. - 10/27/2024
Bayer partners with Impli
Impli’s goal is to advance women’s health and deliver the first real-time hormone monitoring device. - 10/27/2024
Amneal obtains FDA OK for pyridostigmine bromide ER tablets
Pyridostigmine bromide ER is a once-daily soman nerve agent pretreatment pyridostigmine product for the U.S. armed services and U.S. allies. - 10/24/2024
Teva, mAbxience expand partnership for additional oncology biosimilar candidate
The licensing agreement includes exclusive rights for multiple markets, including Europe and the United States. - 10/24/2024
Samsung Bioepis releases 2024 U.S. biosimilar market report
This year’s Q4 report reflects tocilizumab’s market share and wholesale acquisition cost trend analysis after biosimilars launched in Q2.
